openPR Logo
Press release

Companion Diagnostic Devices Global Market Top Key Players – ARUP Laboratories (U.S.), Abbott Laboratories (U.S.), Biogenex Laboratories, Inc. (U.S), Thermo Fisher Scientific (U.S), Ventana Medical Systems Inc. (U.S) and Forecast to 2023

02-28-2018 11:07 AM CET | Health & Medicine

Press release from: wiseguyreports

/ PR Agency: WiseguyReports
Companion Diagnostic Devices Market

Companion Diagnostic Devices Market

Global Companion Diagnostic Devices Market

WiseGuyRerports.com Presents “Combination Aesthetics Market : Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023” New Document to its Studies Database. The Report Contain 220 Pages With Detailed Analysis.

Description

Companion diagnostics are medical devices, often an in-vitro device and provides the information that essential for safe and effective use of the corresponding drug or biotechnology product. Companion diagnostics are often developed along with drugs to aid in selecting or excluding the patient groups for the treatment with particular drug on basis of their biological characters. Companion diagnostics are developed based on biomarkers technology to predict response or severe toxicity of the drugs or biotechnological compounds. Companion diagnostics are majorly used in oncology area. 

Some of the factors like improved efficacy and safety profiles of drugs, Accelerated drug regulatory approvals, reduced healthcare expenditure and drug development costs, increasing partnerships between market players, government organizations and other research firms over the use of co diagnostics, emergence of new pharmaceuticals and diagnostics are driving the growth of the global companion diagnostics market. However, due to the regulatory uncertainty, complex clinical trial procedures and intellectual property issues in certain areas are the few issues which are restraining the growth of the global companion diagnostics devices market. 

Get sample Report @ https://www.wiseguyreports.com/sample-request/2868231-companion-diagnostic-devices-market-global-market-estimation-dynamics-regional-share

 

Global companion diagnostic devices are segmented on the basis of application, technology, end user and geographical region. 

Based on the application, global companion diagnostic devices are segmented as: 
Breast Cancer 
Colorectal Cancer 
Lung Cancer 
Urology 
Melanoma 
Gastric Cancer 
Others 

Based on the technology, global companion diagnostic devices are segmented as: 
Immunohistochemistry 
Molecular Diagnostics 
In-situ Hybridization 
FISH 
CISH 
Real-Time PCR 
Gene Sequencing 

Based on the end-user, global companion diagnostic devices are segmented as: 
Hospitals 
Diagnostic Centres 
Others 

The global companion diagnostic devices market is highly fragmented due to the presence of several established large and small suppliers. The competition in the market will intensify during the forecast period as vendors adopt strategies like M&A to develop new technologies. Product approval and launch will also help to increase the volume of available diagnostic devices in the market. In addition, the vendors also work on differentiating their products based on quality, the accuracy of results, and other value added services as it will help them to gain a competitive edge over their peers. 

Geographically, companion diagnostic devices market is segmented into five regions: North America, Europe, Latin America, Asia-Pacific and Middle East & Africa. North America expected to be major market for companion diagnostics owing to growth innovative technologies in biomarkers, increase in R&D investment in the region. Asia-Pacific and Europe are expected to grow at a significant rate owing to large patent and consumer base, increasing government initiatives developing healthcare infrastructure, and growing disposable income. 

Some of the players in companion diagnostic devices market are F. Hoffmann-La Roche Ltd.(Switzerland), Qiagen Ltd. (Germany), ARUP Laboratories (U.S.), Abbott Laboratories (U.S.), Biogenex Laboratories, Inc. (U.S), Thermo Fisher Scientific (U.S), Ventana Medical Systems Inc. (U.S), Myriad Genetics Inc. (U.S), and Danaher (U.S) and others. 

In June 2015, Ventana Medical Systems, Inc. (RocheGroup) has received USFDA approval for its ventana alk cdx assay, companion diagnostic to aid in the identification of patients for, xalkori (crizotinib) (Pfizer’s FDA approved targeted therapy) 

Complete Report Details @ https://www.wiseguyreports.com/reports/2868231-companion-diagnostic-devices-market-global-market-estimation-dynamics-regional-share

 

Table of Contents -Major Key Points

Executive Summary 

Global Companion Diagnostic Devices Market Introduction 
2.1. Global Companion Diagnostic Devices Market – Taxonomy 
    2.2. Global Companion Diagnostic Devices Market –Definitions 
      2.2.1. Technology 
      2.2.2. Application 
Global Companion Diagnostic Devices Market Dynamics 
3.1. Drivers 
    3.2. Restraints 
    3.3. Opportunities/Unmet Needs of the Market 
    3.4. Trends 
    3.5. Global Companion Diagnostic Devices Market Dynamic Factors - Impact Analysis 
Global Companion Diagnostic Devices Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 
4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
    4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 
    4.3. Market Opportunity Analysis 
Global Companion Diagnostic Devices Market, By Technology, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
5.1. Immunohistochemistry 
      5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      5.1.3. Market Opportunity Analysis 
    5.2. Molecular Diagnostics 
      5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      5.2.3. Market Opportunity Analysis 
    5.3. In-situ Hybridization 
      5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      5.3.3. Market Opportunity Analysis 
    5.4. FISH 
      5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      5.4.3. Market Opportunity Analysis 
    5.5. CISH 
      5.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      5.5.3. Market Opportunity Analysis 
    5.6. Real-Time PCR 
      5.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      5.6.3. Market Opportunity Analysis 
    5.7. Gene Sequencing 
      5.7.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn) 
      5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
      5.7.3. Market Opportunity Analysis 
 ………..CONTINUED

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, Industry research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)             

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Diagnostic Devices Global Market Top Key Players – ARUP Laboratories (U.S.), Abbott Laboratories (U.S.), Biogenex Laboratories, Inc. (U.S), Thermo Fisher Scientific (U.S), Ventana Medical Systems Inc. (U.S) and Forecast to 2023 here

News-ID: 960715 • Views:

More Releases from wiseguyreports

Quality Management System Software Market to Reach USD 20.8 Billion by 2032 | Exclusive Report by Wise Guy Reports
Quality Management System Software Market to Reach USD 20.8 Billion by 2032 | Ex …
Quality Management System Software Market Overview: The Quality Management System Software Market Industry is expected to grow from 9.88(USD Billion) in 2024 to 20.8 (USD Billion) by 2032. The Quality Management System Software Market CAGR (growth rate) is expected to be around 9.76% during the forecast period (2025 - 2032). The Quality Management System (QMS) Software Market has seen robust growth, driven by the increasing need for organizations to ensure compliance
Video Game Development Software Market is Set to Achieve USD 12.45 Billion by 2032 | Exclusive Report by Wise Guy Reports
Video Game Development Software Market is Set to Achieve USD 12.45 Billion by 20 …
Video Game Development Software Market Overview: The Video Game Development Software Market Industry is expected to grow from 9.23(USD Billion) in 2024 to 12.45 (USD Billion) by 2032. The Video Game Development Software Market CAGR (growth rate) is expected to be around 3.82% during the forecast period (2025 - 2032). The video game development software market is a cornerstone of the gaming industry, providing developers with the tools to create interactive
Online Learning Management Systems Market is Expected to Touch USD 44.5 Billion By 2032 | Exclusive Report by Wise Guy Reports
Online Learning Management Systems Market is Expected to Touch USD 44.5 Billion …
Online Learning Management Systems Market Overview: The Online Learning Management Systems Market Industry is expected to grow from 20.96(USD Billion) in 2024 to 44.5 (USD Billion) by 2032. The Online Learning Management Systems Market CAGR (growth rate) is expected to be around 9.86% during the forecast period (2025 - 2032). The Online Learning Management Systems (LMS) market has witnessed remarkable growth in recent years, driven by the increasing adoption of e-learning
Virtual Webcam Market Poised for Explosive Growth, Reaching USD 41.6 Billion by 2032
Virtual Webcam Market Poised for Explosive Growth, Reaching USD 41.6 Billion by …
Virtual Webcam Market Overview: The Virtual Webcam Market Industry is expected to grow from 10.15(USD Billion) in 2024 to 41.6 (USD Billion) by 2032. The Virtual Webcam Market CAGR (growth rate) is expected to be around 19.29% during the forecast period (2025 - 2032). The virtual webcam market is experiencing rapid growth, fueled by increasing demand for remote communication tools, video conferencing, and content creation. Virtual webcams, which simulate camera feeds

All 5 Releases


More Releases for Companion

Companion Animal Medicine Market Healthy Companions, Healthy Profits: Trends in …
Companion Animal Medicine Market to reach over USD 41.71 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Medicine Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats, And Horses), Product (Pharmaceuticals And Medicated Feed Additives), Distribution Channel (Veterinary Hospitals And Clinics), And Indication (Antibiotics and Parasiticides)- Market Outlook
Companion Diagnostics Market - Companion Diagnostics Industry Size, Share, Analy …
Companion diagnostics are medical devices and tests that provide essential information for the safe and effective use of a corresponding drug or biological product. These diagnostics are critical in the field of personalized medicine, as they help identify patients who are most likely to benefit from a particular therapeutic product. The Global Companion Diagnostics Market was valued at US$ 5.59 Billion in 2022 and is projected to reach US$ 13.74
Companion Animal Digital Technology Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Digital Technology Market By Type of Service (Telemedicine, Telehealth, Reminder Applications, Trackers, Wearables, and Platform Market Places) Trends, Industry Competition Analysis, COVID-19 Impact Analysis, Revenue and Forecast Till 2031." features detailed market analysis and an extensive study on the current trends, exploring its significant factors. The Artificial Intelligence (AI) In Beauty and Cosmetics Market
Companion Diagnostics Market - Transforming Patient Outcomes: Pioneering Compani …
Newark, New Castle, USA: The "Companion Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Companion Diagnostics Market: https://www.growthplusreports.com/report/companion-diagnostics-market/8673 This latest report researches the industry structure, sales, revenue,
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S. Moreover, the
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test